Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Sale
Global Gastrointestinal Stromal Tumor Market: By Treatment Type: Targeted Drug Therapy, Chemotherapy, Radiation Therapy, Surgery, Others; By Indication: Stomach, Small Intestine, Others; By End Use; Regional Analysis; Historical Market and Forecast (2016-2026); Competitive Landscape; Industry Events and Developments
Global Gastrointestinal Stromal Tumor Market Outlook
The global gastrointestinal stromal tumor market is expected to grow at a CAGR of 5.8% in the forecast period of 2021-2026.
Growing Awareness Regarding the Disease to Aid the Market Growth of Gastrointestinal Stromal Tumor
The market growth of gastrointestinal stromal tumor is being aided by the growing prevalence of the disease across the globe. The market is propelled by the growing awareness and understanding of this tumor, which has catapulted the market growth tremendously. Further, the ongoing R&D activities across several medical research institutes and organizations worldwide are encouraging the industry growth of gastrointestinal stromal tumor.
Region-wise, North America is a significant market for gastrointestinal stromal tumor and is expected to maintain its significance over the forecast period as well. The healthy market growth in this region could be attributed to the growing adoption of unhealthy dietary options and the consequent bad lifestyles of people, accelerated by the usage of food additives in such food products. Also, the rising prevalence of genetic disorders is a fundamental factor contributing to the speedy growth of this industry in North America in the upcoming years. In addition to this, Europe and the Asia Pacific are expected to observe healthy growth in the forecast period.
Gastrointestinal Stromal Tumor: Industry Definition and Segmentation
Gastrointestinal stromal tumors (GISTs) are referred to as soft tissue sarcomas, which can be situated in any part of the digestive system. They are generally found in the stomach and small intestine. GISTs begin to form in specialized nerve cells found in the walls of the digestive system.
On the basis of treatment type, the market is divided into:
- Targeted Drug Therapy
- Chemotherapy
- Radiation Therapy
- Surgery
- Others
Based on indication, the industry can be segmented into:
- Stomach
- Small Intestine
- Others
By end use, the industry is categorised into:
- Hospitals
- Cancer Treatment Centers
- Clinics
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Growing Focus on Technological Developments to Aid the Market Growth of Gastrointestinal Stromal Tumor
The gastrointestinal stromal tumor industry is being driven by the developments in clinical practice guidelines. Further, the robust growth of the healthcare sector and the growing focus on technological developments in this industry is expected to fuel the market growth of gastrointestinal stromal tumor in the forecast period. Furthermore, the growing investments in the medical sector, particularly in emerging economies, are expected to provide lucrative opportunities in the forecast period. All the aforementioned factors are expected to bolster the market growth in the coming years.
Key Industry Players in the Global Gastrointestinal Stromal Tumor Market
The report gives a detailed analysis of the following key players in the global gastrointestinal stromal tumor market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Pfizer Inc.
- Novartis AG
- Bayer AG
- Blueprint Medicines Corporation
- Others
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Gastrointestinal Stromal Tumor Market Analysis
8.1 Key Industry Highlights
8.2 Global Gastrointestinal Stromal Tumor Historical Market (2016-2020)
8.3 Global Gastrointestinal Stromal Tumor Market Forecast (2021-2026)
8.4 Global Gastrointestinal Stromal Tumor Market by Treatment Type
8.4.1 Targeted Drug Therapy
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2016-2020)
8.4.1.3 Forecast Trend (2021-2026)
8.4.2 Chemotherapy
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2016-2020)
8.4.2.3 Forecast Trend (2021-2026)
8.4.3 Radiation Therapy
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2016-2020)
8.4.3.3 Forecast Trend (2021-2026)
8.4.4 Surgery
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2016-2020)
8.4.4.3 Forecast Trend (2021-2026)
8.4.5 Others
8.5 Global Gastrointestinal Stromal Tumor Market by Indication
8.5.1 Stomach
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2016-2020)
8.5.1.3 Forecast Trend (2021-2026)
8.5.2 Small Intestine
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2016-2020)
8.5.2.3 Forecast Trend (2021-2026)
8.5.3 Others
8.6 Global Gastrointestinal Stromal Tumor Market by End Use
8.6.1 Hospitals
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2016-2020)
8.6.1.3 Forecast Trend (2021-2026)
8.6.2 Cancer Treatment Centers
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2016-2020)
8.6.2.3 Forecast Trend (2021-2026)
8.6.3 Clinics
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2016-2020)
8.6.3.3 Forecast Trend (2021-2026)
8.6.4 Others
8.7 Global Gastrointestinal Stromal Tumor Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2016-2020)
9.1.2 Forecast Trend (2021-2026)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2016-2020)
9.2.2 Forecast Trend (2021-2026)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2016-2020)
9.3.2 Forecast Trend (2021-2026)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2016-2020)
9.4.2 Forecast Trend (2021-2026)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2016-2020)
9.5.2 Forecast Trend (2021-2026)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Pfizer Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Novartis AG
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Bayer AG
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Blueprint Medicines Corporation
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Others
13 Industry Events and Developments
List of Figures and Tables
1. Global Gastrointestinal Stromal Tumor Market: Key Industry Highlights, 2016 and 2026
2. Global Gastrointestinal Stromal Tumor Historical Market: Breakup by Treatment Type (USD Billion), 2016-2020
3. Global Gastrointestinal Stromal Tumor Market Forecast: Breakup by Treatment Type (USD Billion), 2021-2026
4. Global Gastrointestinal Stromal Tumor Historical Market: Breakup by Indication (USD Billion), 2016-2020
5. Global Gastrointestinal Stromal Tumor Market Forecast: Breakup by Indication (USD Billion), 2021-2026
6. Global Gastrointestinal Stromal Tumor Historical Market: Breakup by End Use (USD Billion), 2016-2020
7. Global Gastrointestinal Stromal Tumor Market Forecast: Breakup by End Use (USD Billion), 2021-2026
8. Global Gastrointestinal Stromal Tumor Historical Market: Breakup by Region (USD Billion), 2016-2020
9. Global Gastrointestinal Stromal Tumor Market Forecast: Breakup by Region (USD Billion), 2021-2026
10. North America Gastrointestinal Stromal Tumor Historical Market: Breakup by Country (USD Billion), 2016-2020
11. North America Gastrointestinal Stromal Tumor Market Forecast: Breakup by Country (USD Billion), 2021-2026
12. Europe Gastrointestinal Stromal Tumor Historical Market: Breakup by Country (USD Billion), 2016-2020
13. Europe Gastrointestinal Stromal Tumor Market Forecast: Breakup by Country (USD Billion), 2021-2026
14. Asia Pacific Gastrointestinal Stromal Tumor Historical Market: Breakup by Country (USD Billion), 2016-2020
15. Asia Pacific Gastrointestinal Stromal Tumor Market Forecast: Breakup by Country (USD Billion), 2021-2026
16. Latin America Gastrointestinal Stromal Tumor Historical Market: Breakup by Country (USD Billion), 2016-2020
17. Latin America Gastrointestinal Stromal Tumor Market Forecast: Breakup by Country (USD Billion), 2021-2026
18. Middle East and Africa Gastrointestinal Stromal Tumor Historical Market: Breakup by Country (USD Billion), 2016-2020
19. Middle East and Africa Gastrointestinal Stromal Tumor Market Forecast: Breakup by Country (USD Billion), 2021-2026
20. Global Gastrointestinal Stromal Tumor Market Structure
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 1999
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst SupportFree Update in 180 DaysSingle User License
$3099$2499-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst SupportFree Update in 180 DaysFive User License
$4099$3499-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
Free Update in 180 Days
Corporate License
$5099$4499-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
Free Update in 180 Days
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar ReportsPrecision Medicine Market Size, Share, Analysis, Trends 2021-2026
Empty Capsules Market Size, Share, Analysis, Growth, Report 2020-2026
The global human insulin market attained USD 36 billion in 2020. The market is expected to grow at a CAGR of 4.7% in the forecast period of 2021-2026 to attain USD 48 billion by 2026.
The global telemedicine market attained a value of USD 55 billion in 2020, driven by the rising demand for cost-effective and user-friendly healthcare services. Aided by the increasing technological a...
The global epharmacy market is being driven by the rising internet penetration. Aided by the growing technological advancements, the market is expected to witness a further growth in the forecast peri...
NEWSLETTER